The awakening of an advanced malignant cancer: An insult to the mitochondrial genome
In only months-to-years a primary cancer can progress to an advanced phenotype that is metastatic and resistant to clinical treatments. As early as the 1900s, it was discovered that the progression of a cancer to the advanced phenotype is often associated with a shift in the metabolic profile of the...
Saved in:
Published in | Biochimica et biophysica acta Vol. 1820; no. 5; pp. 652 - 662 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.05.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In only months-to-years a primary cancer can progress to an advanced phenotype that is metastatic and resistant to clinical treatments. As early as the 1900s, it was discovered that the progression of a cancer to the advanced phenotype is often associated with a shift in the metabolic profile of the disease from a state of respiration to anaerobic fermentation — a phenomenon denoted as the Warburg Effect.
Reports in the literature strongly suggest that the Warburg Effect is generated as a response to a loss in the integrity of the sequence and/or copy number of the mitochondrial genome content within a cancer.
Multiple studies regarding the progression of cancer indicate that mutation, and/or, a flux in the copy number, of the mitochondrial genome content can support the early development of a cancer, until; the mutational load and/or the reduction-to-depletion of the copy number of the mitochondrial genome content induces the progression of the disease to an advanced phenotype.
Collectively, evidence has revealed that the human cell has incorporated the mitochondrial genome content into a cellular mechanism that, when pathologically actuated, can de(un)differentiate a cancer from the parental tissue of origin into an autonomous disease that disrupts the hierarchical structure-and-function of the human body. This article is part of a Special Issue entitled: Biochemistry of Mitochondria.
►This review describes change in mitochondrial genome in cancer. ►Evidence shows that mitochondrial genome is predisposed to mutation in carcinogenesis. ►Then a burst of mutations occurred associated with advanced malignant phenotype. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.bbagen.2011.08.017 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-3 |
ISSN: | 0304-4165 0006-3002 1872-8006 0006-3002 |
DOI: | 10.1016/j.bbagen.2011.08.017 |